IN.PACT Global Clinical Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1535 participants.

Also called NCT01609296

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,535 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01609296
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Argentina, Australia, Austria, Belgium, Canada, Colombia, Czechia, Egypt, Finland, France, Germany, Greece, Hungary, Israel, Italy, Lithuania, Netherlands, Poland, Portugal, Russia, Singapore, Slovakia, Slovenia, South Korea, Sweden, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01609296. Allocation not applicable; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2016-04 (actual). Results posted on 2019-01-28.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
IN.PACT Global Clinical Study
Condition
Peripheral Arterial Disease
Intervention (Device)
IN.PACT Admiral™ Drug Eluting Balloon
Lead sponsor
Medtronic Endovascular (class: industry)

Record details

Record id
cardio:ct-nct01609296
Content hash
edabb8b0388c04806466dbaf67e964b4283d92fe1d19f478f71a0603e92f1794